Knocking down SKA3 combined with HIF-1α inhibitors (PX-478) suppressed tumor cell glucose metabolic reprogramming, weakened hypoxia tolerance, and synergistically inhibited LUAD liver metastasis. The gene discussed is HIF1A; the disease is neoplasm.